Malaria is caused by protozoan erythrocytic parasites of the Plasmodium genus, with P. falciparum being the most dangerous and widespread disease-causing species. Falcipain-2 (FP-2) of P. falciparum is a papain-family (C1A) cysteine protease that plays an important role in the parasite life-cycle by degrading erythrocyte proteins, most notably hemoglobin. Inhibition of FP-2 and its paralogues prevents parasite maturation, suggesting these proteins may be valuable targets for the design of novel antimalarial drugs, but lack of structural knowledge has impeded progress towards the rational discovery of potent, selective and efficacious inhibitors. As a first step towards this goal, we present here the crystal structure of mature FP-2 at 3.1 ? resolution, revealing novel structural features of the FP-2 subfamily proteases including a dynamic ¦Â-hairpin hemoglobin-binding motif, a flexible amino-terminal alpha-helical extension, and a unique active-site cleft. We also demonstrate by biochemical methods that mature FP-2 can proteolytically process its own precursor in trans at neutral to weakly alkaline pH, that the binding of hemoglobin to FP-2 is strictly pH-dependent, and that FP-2 preferentially binds methemoglobin over hemoglobin. Since the specificity and proteolytic activity of FP-2 towards its multiple targets appears to be pH- dependent, we suggest that environmental pH may play an important role in orchestrating FP-2 function over the different life stages of the parasite. Moreover, it appears that selectivity of FP-2 for methemoglobin may represent an evolutionary adaptation to oxidative stress conditions within the host cell.